Tags: Coronavirus | Coronavirus Special | Health Topics | Cold/Flu | covid-19 | veterinary | drug

Veterinary Drug Associated With Lower Mortality for COVID

Chloroquine, Hydroxychloroquine Sulfate, Zinc, Ivermectin and Avigan drugs sitting on a table
(Dreamstime/Sergio Yoneda)

By    |   Tuesday, 13 October 2020 04:33 PM

A drug originally developed in the 1970s as a veterinary medicine to combat parasites in livestock was associated with lower death rates among people suffering from COVID-19, a study conducted in Florida and published in the medical journal Chest revealed.

Patients who received ivermectin, which was called a "wonder drug" in a study a decade ago for the treatment of the parasitic diseases, river blindness – or onchocerciasis – and lymphatic filariasis, had a mortality rate of 15% compared to 25% who did not receive the drug. The results were even more significant for COVID-19 patients with "severe pulmonary involvement."

The mortality rate was only 38% for those patients who received ivermectin compared with 80.7% for the patients that did not receive it.

Most patients in both groups also received hydroxychloroquine and/or azithromycin.

"In this multihospital retrospective cohort study, we observed a significant association with ivermectin on improved survival for patients admitted with COVID-19," the authors said. "This association was also seen in the subset of patients with severe pulmonary disease."

Ivermectin was shown to inhibit replication of the SARS-CoV-2 virus that causes COVID-19 in laboratory tests, which led to "off-label" use, the study's authors said in their report. That led to a warning by the Food & Drug Administration on April 10 against its use.

The Florida researchers reviewed the treatment and results of 280 COVID-19 patients hospitalized at four Broward Health hospitals between March 15 and May 11.

One hundred seventh-three patients were treated with ivermectin and 107 were not.

"After multivariate adjustment for confounders and mortality risks, the mortality difference remained significant," the authors said, 13.3% for the ivermectin-treated patients versus 24.5% without.

© 2020 Newsmax. All rights reserved.


   
1Like our page
2Share
US
A drug originally developed in the 1970s as a veterinary medicine to combat parasites in livestock was associated with lower death rates among people suffering from COVID-19, a study conducted in Florida and published in the medical journal Chest revealed.
covid-19, veterinary, drug, mortality, pandemic, treatments, veterinary, medicine
276
2020-33-13
Tuesday, 13 October 2020 04:33 PM
Newsmax Media, Inc.
 

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

NEWSMAX.COM
America's News Page
© Newsmax Media, Inc.
All Rights Reserved